COVID-19

Browse COVID-19 Content

Consumer Healthcare Products Association (CHPA) President and CEO, Scott Melville, issued the following statement upon final passage of the CARES Act.

Mar 27, 2020

Find detailed information about each section of the CARES Act, which was passed in 2020 in response to the COVID-19 pandemic.

Mar 25, 2020

It is imperative that the federal, state, and local governments come together with uniform definitions of “critical infrastructure”, making clear what manufacturers must continue to operate, and take seriously the need to transport those products and keep operations running.

Mar 25, 2020

We strongly agree that healthcare product manufacturers have a central role to play in the fight against this pandemic. Provided employers comply with CDC guidelines to protect workers, healthcare product manufacturers have the special responsibility to maintain their current work schedules.

Mar 20, 2020

CHPA continues to closely monitor the rapidly-evolving Coronavirus Disease 2019 (COVID-19) outbreak.

Mar 6, 2020

The four leading trade associations representing the dietary supplement industry are concerned that some marketers of dietary supplements may be promoting them with claims of prevention or treatment of Coronavirus.

Feb 11, 2020

The observational Internet survey results pre-published in the American Journal of Gastroenterology reporting an association between use of proton-pump inhibitor (PPI) medicines and self-reported positive tests for COVID-19 among people taking PPIs do not prove cause-and-effect.

Jan 10, 2020

State by state listing of whether OTC medicines are exempt from state sales tax or not.

Jun 1, 2018

Given pharmacists' drug knowledge and public accessibility, states are exploring expanding their scope of practice permanently after the pandemic emergency measures expire. Empowering pharmacists to dispense products like oral contraceptives, and other consumer healthcare products could improve access and outcomes.

Filter Results